NCT00528541View on ClinicalTrials.gov

Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia

PHASE4CompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Spasmodic Torticollis
Interventions
BIOLOGICAL

botulinum toxin type A

200 Units at Visit 1 (Day 1)

BIOLOGICAL

botulinum toxin type A

750 Units at Visit 1 (Day 1)

Trial Locations (5)

Unknown

Adelaide

Zagreb

Rome

Krakow

Istanbul

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY